Triamcinolone Acetonide as an Adjunctive to VPDT in ARMD.

Triamcinolone Acetonide as an Adjunctive Treatment to Verteporfin Therapy in Neovascular Age-Related Macular Degeneration: Randomized Placebo-Controlled Clinical Trial.

A 24 - month Study looking at the the changes in visual acuity of patients receiving PDT therapy in conjunction with intravitreal triamcinolone.

This study will evaluate the effect of Triamcinolone Acetonide in conjunction with photodynamic therapy for the treatment of sub-foveal choroidal neovascular membranes secondary to age-related macular degeneration.

Inclusion Criteria:

• Individuals with predominantly classic, subfoveal CNV secondary to AMD.
• No previous PDT Treatment in study eye.

Exclusion Criteria:

• CNV from conditions, other than AMD.
• Other disease that could be responsible for decreased vision.